FDA Weighs Stronger Warning on Antidepressants

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/3917982/3917983" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Scientific advisers to the Food and Drug Administration meeting in Washington, D.C. agree that there is a link between antidepressants and an increased risk of suicidal behavior among some children. FDA staff told the panel members that a new warning added in March to antidepressants called SSRIs appeared to have little impact on children's use of the drugs. The panel is expected to vote on whether stronger warning labels or other restrictions are needed on the drugs. Hear NPR's Melissa Block and NPR's Joanne Silberner.



Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.